dorsaVi (ASX:DVL) -
CEO, Andrew Ronchi Source: North Road Physiotherapy
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • dorsaVi (DVL) extends its master services agreement (MSA) with medical technology and services provider Medtronic by six months
  • The parties signed an initial 12-month agreement in March
  • The extension will allow for further optimisation of DVL’s medical-grade sensor technology by building on insights gathered so far
  • While the original MSA was valued at around US$330,000 (A$446,500), the six-month addition tacks on roughly US$171,000 (A$231,000)
  • dorsaVi shares have closed flat at 2.6 cents on August 5

dorsaVi (DVL) has extended its agreement with medical technology and services provider Medtronic for a further six months.

DVL develops innovative motion analysis devices for use in clinical applications, elite sports, and occupational health and safety.

The parties solidified their commercial relationship through an initial master services agreement (MSA) signed back in March, following an evaluation deal made in December last year.

The companies agreed to analyse data on patients wearing dorsaVi medical-grade sensors over an initial 12-month period.

To this end, the six-month extension is said to be worth roughly US$171,000 (A$231,000) on top of the MSA’s original value in the realm of US$330,000 (A$446,500).

Accordingly, DVL said the longer deal aimed to further optimise its technology by building on the insights gathered from the MSA so far.

dorsaVi CEO Andrew Ronchi said the extension of the agreement was a testament to the hard work of his team and was a strong validation of DVL’s world-leading technology.

“This agreement further highlights the different potential uses of our technology, exploring new applications and potential partnerships to deliver shareholder value,” Dr Ronchi said.

DVL’s partner Medtronic is headquartered in Dublin and has operations in 150 countries worldwide. The company is focussed on alleviating pain, restoring health and extending life for millions of people around the world.

dorsaVi shares closed flat at 2.6 cents on August 5.

DVL by the numbers
More From The Market Online
Image of two logos: Bigtincan Holdings & Vector Capital.

Deal done: Instos take control, locking in Bigtincan’s takeover

Bigtincan Holdings will be owned by US private equity firm Vector Capital in the wake of…
Television headstone concept

Birddog Tech delisting off the ASX after painful 3 years. But did it ever make sense at all?

Birddog Technology has confirmed it's delisting off the ASX after listing back in December of 2021…
Wall of TVs

‘Value for money’: Swift inks 2 renewals contracts in mining sector for $1.3 million

Swift Network Group Ltd has renewed contracts with 2 longstanding customers which together are worth $1.3…
Redundancy concept

Playside kicks off restructure to recover share price; mediocre FY25 guidance unchanged

Playside Studios (ASX:PLY) has confirmed it is today kicking off an operational restructure with redundancies saving…